TOBAM’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$115K Sell
353
-3,013
-90% -$982K 0.04% 136
2025
Q1
$909K Sell
3,366
-8,418
-71% -$2.27M 0.39% 71
2024
Q4
$2.77M Sell
11,784
-19,683
-63% -$4.63M 0.85% 42
2024
Q3
$8.65M Buy
31,467
+1,736
+6% +$477K 1.58% 20
2024
Q2
$7.23M Sell
29,731
-39,331
-57% -$9.56M 1.13% 32
2024
Q1
$10.3M Sell
69,062
-21,979
-24% -$3.28M 0.93% 38
2023
Q4
$17.4M Sell
91,041
-12,003
-12% -$2.3M 1.52% 28
2023
Q3
$18.2M Sell
103,044
-5,584
-5% -$989K 1.46% 27
2023
Q2
$20.6M Sell
108,628
-18,132
-14% -$3.44M 1.56% 26
2023
Q1
$25.4M Buy
126,760
+10,712
+9% +$2.15M 1.67% 23
2022
Q4
$27.6M Buy
116,048
+15,183
+15% +$3.61M 1.83% 21
2022
Q3
$20.2M Sell
100,865
-79,236
-44% -$15.9M 1.41% 25
2022
Q2
$26.3M Buy
180,101
+24,516
+16% +$3.58M 1.65% 22
2022
Q1
$25.4M Buy
155,585
+73,732
+90% +$12M 1.28% 29
2021
Q4
$13.9M Buy
81,853
+72,659
+790% +$12.3M 0.62% 59
2021
Q3
$1.74M Buy
9,194
+537
+6% +$101K 0.07% 108
2021
Q2
$1.47M Sell
8,657
-29,764
-77% -$5.05M 0.06% 117
2021
Q1
$5.43M Sell
38,421
-37,863
-50% -$5.35M 0.23% 85
2020
Q4
$9.92M Buy
76,284
+5,123
+7% +$666K 0.44% 70
2020
Q3
$10.4M Buy
71,161
+21,412
+43% +$3.12M 0.52% 56
2020
Q2
$7.37M Buy
+49,749
New +$7.37M 0.47% 57
2019
Q3
Sell
-844
Closed -$61K 120
2019
Q2
$61K Sell
844
-115,358
-99% -$8.34M ﹤0.01% 114
2019
Q1
$10.9M Sell
116,202
-157,403
-58% -$14.7M 0.55% 54
2018
Q4
$19.9M Buy
273,605
+28,824
+12% +$2.1M 0.96% 39
2018
Q3
$21.4M Sell
244,781
-42,933
-15% -$3.76M 0.91% 39
2018
Q2
$28.3M Buy
287,714
+78,265
+37% +$7.71M 1.17% 32
2018
Q1
$24.9M Buy
209,449
+97,895
+88% +$11.7M 1.02% 36
2017
Q4
$14.2M Buy
+111,554
New +$14.2M 0.61% 63
2015
Q4
Sell
-116,310
Closed -$9.35M 110
2015
Q3
$9.35M Buy
116,310
+80,014
+220% +$6.43M 0.36% 61
2015
Q2
$4.35M Buy
+36,296
New +$4.35M 0.16% 90